Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-09 6:41 pm Unchanged | 2026-02-03 | 13D | Lucid Diagnostics Inc. LUCD | PAVmed Inc. PAVM | 38,816,903 27.500% | 0 (Unchanged) | Filing History |
| 2025-10-10 9:45 pm Purchase | 2025-10-09 | 13D | Lucid Diagnostics Inc. LUCD | PAVmed Inc. PAVM | 38,816,903 28.300% | 38,816,903 (New Position) | Filing History |
| 2025-08-14 3:19 pm Purchase | 2025-07-01 | 13G | PAVmed Inc. PAVM | Sargent Investment Group LLC | 33,543 5.800% | 33,543 (New Position) | Filing History |
| 2025-05-15 1:14 pm Purchase | 2025-03-31 | 13G | PAVmed Inc. PAVM | FIRST MANHATTAN CO. LLC. | 23,803 4.300% | 3,803 (+19.02%) | Filing History |
| 2025-02-28 5:29 pm Purchase | 2025-02-21 | 13G | PAVmed Inc. PAVM | Tasso Partners, LLC | 85,812 18.900% | 85,812 (New Position) | Filing History |
| 2025-02-13 1:40 pm Purchase | 2024-12-31 | 13G | PAVmed Inc. PAVM | Ayrton Capital LLC | 40,877 9.900% | 12,510 (+44.10%) | Filing History |
| 2024-12-12 4:30 pm Unchanged | 2024-11-22 | 13D | Lucid Diagnostics Inc. LUCD | PAVmed Inc. PAVM | 31,302,444 52.700% | 0 (Unchanged) | Filing History |
| 2024-11-14 10:02 am Purchase | 2024-09-30 | 13G | PAVmed Inc. PAVM | FIRST MANHATTAN CO. LLC. | 20,000 5.770% | 20,000 (New Position) | Filing History |
| 2024-09-23 8:46 pm Purchase | 2024-08-30 | 13G | PAVmed Inc. PAVM | Dubreville Anthony Michael | 20,209 5.500% | 20,209 (New Position) | Filing History |
| 2024-02-20 4:45 pm Sale | 2024-02-15 | 13D | Lucid Diagnostics Inc. LUCD | PAVmed Inc. PAVM | 31,302,444 65.200% | -3,331,747 (-9.62%) | Filing History |
| 2024-02-14 3:38 pm Purchase | 2023-12-31 | 13G | PAVmed Inc. PAVM | Ayrton Capital LLC | 28,367 9.900% | 28,367 (New Position) | Filing History |
| 2024-02-02 5:11 pm Purchase | 2024-01-26 | 13D | Lucid Diagnostics Inc. LUCD | PAVmed Inc. PAVM | 34,634,191 72.200% | 3,331,771 (+10.64%) | Filing History |
| 2022-12-02 5:22 pm Purchase | 2022-11-30 | 13D | Lucid Diagnostics Inc. LUCD | PAVmed Inc. PAVM | 31,302,420 73.700% | 3,375,230 (+12.09%) | Filing History |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | PAVmed Inc. PAVM | BlackRock Inc. BLK | 3,200 1.600% | -7,435 (-69.91%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | PAVmed Inc. PAVM | BlackRock Inc. BLK | 10,636 5.400% | 10,636 (New Position) | Filing History |
| 2021-10-27 5:26 pm Purchase | 2021-10-18 | 13D | Lucid Diagnostics Inc. LUCD | PAVmed Inc. PAVM | 27,927,190 75.500% | 27,927,190 (New Position) | Filing History |
| 2021-10-06 2:28 pm Sale | 2021-10-04 | 13G | PAVmed Inc. PAVM | SIROVICH MATTHEW | 5,565 2.900% | -6,746 (-54.79%) | Filing History |